MXPA04005901A - Taxane based compositions and methods of use. - Google Patents

Taxane based compositions and methods of use.

Info

Publication number
MXPA04005901A
MXPA04005901A MXPA04005901A MXPA04005901A MXPA04005901A MX PA04005901 A MXPA04005901 A MX PA04005901A MX PA04005901 A MXPA04005901 A MX PA04005901A MX PA04005901 A MXPA04005901 A MX PA04005901A MX PA04005901 A MXPA04005901 A MX PA04005901A
Authority
MX
Mexico
Prior art keywords
methods
taxane
compositions
based compositions
disclosed
Prior art date
Application number
MXPA04005901A
Other languages
Spanish (es)
Inventor
A Smith Gregory
Original Assignee
Ivax Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ivax Research Inc filed Critical Ivax Research Inc
Priority claimed from PCT/US2002/041632 external-priority patent/WO2003057208A1/en
Publication of MXPA04005901A publication Critical patent/MXPA04005901A/en

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

Disclosed are taxane-based compostions and methods of using the same to achieve target blood levels of a taxane in a mammal, e.g., to treat taxane-responsive malignant and non-malignant diseases. Compositions of the invention exhibit long-term stability and overall palatability. Also disclosed are methods for using the compositions as analytical tools for pharmacokinetic studies.
MXPA04005901A 2001-12-28 2002-12-27 Taxane based compositions and methods of use. MXPA04005901A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34429101P 2001-12-28 2001-12-28
PCT/US2002/041632 WO2003057208A1 (en) 2001-12-28 2002-12-27 Taxane based compositions and methods of use

Publications (1)

Publication Number Publication Date
MXPA04005901A true MXPA04005901A (en) 2004-09-13

Family

ID=35788840

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04005901A MXPA04005901A (en) 2001-12-28 2002-12-27 Taxane based compositions and methods of use.

Country Status (1)

Country Link
MX (1) MXPA04005901A (en)

Similar Documents

Publication Publication Date Title
CY1121314T1 (en) RAPAMYCINE PRODUCER FOR THE TREATMENT OF LUNG CANCER
SG160412A1 (en) Anti-igfr1 antibody therapeutic combinations
ATE538215T1 (en) EXPRESSION PROFILE OF PROSTATE CARCINOMA
MXPA03007837A (en) Compositions for delivering bisphosphonates.
BRPI0409133A (en) pharmaceutical formulations containing methylnaltrexone
MY129263A (en) Vaccine composition
WO2007011693A3 (en) Compositions of placentally-derived stem cells for the treatment of cancer
ATE556706T1 (en) FAT ALCOHOL-DRUG CONJUGATES
BRPI0618488A2 (en) Hepatocyte Growth Factor Intron Fusion Proteins
HK1120427A1 (en) Anti-glypican-3 antibody
RS20050708A (en) Aminoheteroaryl compounds as protein kinase inhibitors
HK1102991A1 (en) Pharmaceutical formulation of decitabine
DE69834923D1 (en) Hochgradig lipophile camptothecin-derivate
MX2007003031A (en) Heteroaryl compounds for use as betamimetics in the treatment of respiratory diseases.
AR027715A1 (en) COMPOSITIONS BASED ON TAXANS AND METHODS OF USE OF THE SAME
TW200510367A (en) Novel lapachone compounds, their preparation, and the use thereof
WO2003045319A3 (en) Targeted therapeutics and uses thereof
WO2004098377A3 (en) Methods and compositions for diagnosis and therapy of parkin-associated disorders
HK1040983A1 (en) Quinones for treatment of diseases.
MX2007001953A (en) Enantiomers of selected fused pyrimidones and uses in the treatment and preventi on of cancer.
MXPA05012894A (en) Tetrazol benzofurancarboxamides with p13k aktivity as therapeutic agents.
WO2003017939A3 (en) Piperazinone compounds as anti-tumor and anti-cancer agents and methods of treatment
WO2004073615A8 (en) Deazaflavin compounds and methods of use thereof
WO2004091506A3 (en) Taxane-based compositions and methods of use
HK1074840A1 (en) Novel dithiolopyrrolones with therapeutic activity